Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Matteo GuerraHélène PasquerRafael Daltro de OliveiraJuliette Soret-DulphyNabih MaslahLin-Pierre ZhaoClémence MarcaultMarine CazauxNicolas GauthierEmmanuelle VergerNathalie ParquetWilliam VainchenkerEmmanuel RaffouxStephane GiraudierBruno CassinatJean-Jacques KiladjianLina BenajibaPublished in: American journal of hematology (2024)
Comparative clinical characteristics, molecular landscape and prognosis scoring for primary (PMF) and secondary myelofibrosis (SMF).